Skip to content
DraconiticResearch
Search Sources API
190,335 studies31 sourcesUpdated 34 min ago
PreprintarXiv licencearXiv

Mutation Order and Selection Shape Intratumor Heterogeneity in Tumor Evolution

Abstract

Cancer progression often requires multiple driver mutations, but the same drivers may be acquired in different orders. How these pathways jointly shape tumor clonal structure remains unclear. We develop a multitype branching-process model in which malignant transformation requires two driver mutations, distinguishing malignant cells by mutation order and the independent transformation event that founded their clone. Under a successive exponential approximation, we establish point-process limits for pathway-specific clone sizes and derive a closed-form expression for the limiting expected Simpson's index of the combined malignant population. When both mutation orders yield malignant cells with the same net growth rate, the index decomposes into effective pathway weights, determined by mutation rates and birth-death dynamics at preceding stages, and within-pathway concentration terms, determined by intermediate-to-malignant growth-rate ratios. A driver's effect on heterogeneity thus depends critically on when it is acquired. A strong driver acquired early expands the intermediate lineage and increases the supply of independent malignant founders, whereas the same driver acquired last strengthens the growth and age advantage of early-founded malignant clones. Under additive fitness effects, these opposing mechanisms can produce a non-monotone relationship between selective advantage and clonal concentration. Threshold-like non-additive fitness effects can generate highly concentrated malignant populations, while order-dependent terminal fitness causes the faster-growing pathway to dominate asymptotically. These results show how mutation order, mutational accessibility, selection, and epistasis jointly determine lineage-level intratumor heterogeneity.

Related

  1. A Weighted Estimation Approach to Correct for Imperfect Mutation Detection Due to Intra-tumor Heterogeneity in Tumor Sequencing
    A. Mauguen, I. ostrovnaya
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
  2. A diffusion model of viral evolution predicts mutation fitness and evolutionary trajectories
    J. Wu, X. Ding, A. Wu
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  3. Mutation breeding for quantitative traits in the era of genomic selection
    C. J. Yang, R. Sharma, I. Mackay +1
    bioRxivPreprintCC BYFull textGenetics & genomicsbioRxiv
  4. Mutation--selection balance on an infinite trait space: confinement, drift and equilibrium
    Phil. Pollett
    arXivPreprintCC BY 4.0Full textEvolutionary biologyProbabilityarXiv
  5. Causal inference clarifies the roles of background selection and mutation rate variation in shaping human genetic diversity
    G. V. Barroso, N. W. Collier, C. Di +2
    bioRxivPreprintCC BY-NCFull text1 citedEvolutionary biologybioRxiv
BibTeX
@misc{chu2026mutation,
  title = {{Mutation Order and Selection Shape Intratumor Heterogeneity in Tumor Evolution}},
  author = {Yichen Chu and Xiaoxia Sheng and Xuanming Zhang and Zicheng Wang},
  howpublished = {arXiv},
  year = {2026},
  month = sep,
  doi = {10.48550/arxiv.2609.25838},
  eprint = {2609.25838},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2609.25838},
}
RIS
TY  - UNPB
TI  - Mutation Order and Selection Shape Intratumor Heterogeneity in Tumor Evolution
AU  - Yichen Chu
AU  - Xiaoxia Sheng
AU  - Xuanming Zhang
AU  - Zicheng Wang
PY  - 2026
DA  - 2026/09/22
PB  - arXiv
DO  - 10.48550/arxiv.2609.25838
UR  - https://arxiv.org/abs/2609.25838
AB  - Cancer progression often requires multiple driver mutations, but the same drivers may be acquired in different orders. How these pathways jointly shape tumor clonal structure remains unclear. We develop a multitype branching-process model in which malignant transformation requires two driver mutations, distinguishing malignant cells by mutation order and the independent transformation event that founded their clone. Under a successive exponential approximation, we establish point-process limits for pathway-specific clone sizes and derive a closed-form expression for the limiting expected Simpson's index of the combined malignant population. When both mutation orders yield malignant cells with the same net growth rate, the index decomposes into effective pathway weights, determined by mutation rates and birth-death dynamics at preceding stages, and within-pathway concentration terms, determined by intermediate-to-malignant growth-rate ratios. A driver's effect on heterogeneity thus depends critically on when it is acquired. A strong driver acquired early expands the intermediate lineage and increases the supply of independent malignant founders, whereas the same driver acquired last strengthens the growth and age advantage of early-founded malignant clones. Under additive fitness effects, these opposing mechanisms can produce a non-monotone relationship between selective advantage and clonal concentration. Threshold-like non-additive fitness effects can generate highly concentrated malignant populations, while order-dependent terminal fitness causes the faster-growing pathway to dominate asymptotically. These results show how mutation order, mutational accessibility, selection, and epistasis jointly determine lineage-level intratumor heterogeneity.
ER  -